Thinking from treatment outcomes, patients and their health-related life situation are a major growing health care focus area.
Specifically focusing on patients can improve understanding which care interventions are relevant and helpful for them, their personal contexts and relations and which of the interventions are doable societally and economically.
On the macro level, governments, payers and companies are looking at a healthier society, which equates to less costs and better productivity, and on a personal level to better health, more impact and a quality of life bonus.
Payers and governments want to have more preventive and non-pharmaceutical solutions to both improve the patients’ end results (outcomes) while at the same time cutting the spiraling costs of healthcare services. Drugs are becoming more just one player in a multi-layered healthcare instruments convergence.